Heroin addiction rarely stays inside one person. When two people share a home, a routine, a social circle, and often a supply, opioid use disorder stops being an individual condition and becomes something the relationship organizes itself around. Sleep, money, work, parenting, and intimacy all bend toward the next dose. By the time most couples start searching for help, they are not only trying to stop using — they are trying to figure out whether the relationship itself can survive stopping.
Heroin (diacetylmorphine) is a semi-synthetic opioid derived from morphine. In California it circulates most commonly as black tar heroin and, increasingly, as powder that may not be heroin at all. It is injected, smoked, or snorted, and the route matters clinically: injection carries the highest overdose and infection risk, while smoking and snorting still produce full dependence and are not meaningfully safer over time.
Heroin binds to mu-opioid receptors concentrated in brain regions governing pain, breathing, reward, and stress response. That binding triggers a large release of dopamine in the reward pathway — far larger and faster than anything ordinary life produces. The brain, which is built to maintain equilibrium, responds by reducing its own opioid signaling and dampening receptor sensitivity. This adaptation is the biological engine underneath everything else. According to the National Institute on Drug Abuse, repeated opioid exposure produces durable changes in the neural circuits that regulate reward, stress, and self-control, which is why willpower alone is such an unreliable treatment plan.
Three related things follow. Tolerance means the original amount stops producing the original effect, so use escalates. Physical dependence means the body now requires the drug to function normally, so its absence produces withdrawal. Craving means opioid-associated cues — a person, a place, a payday, an argument — generate an intense pull toward use that can arrive long after the last dose. Tolerance and dependence are physiological and can occur with prescribed opioids taken exactly as directed. Opioid use disorder, as defined in the DSM-5-TR, is the broader clinical diagnosis that also involves loss of control, continued use despite harm, and the erosion of everything that used to matter.
Much of what is sold as heroin in California now contains illicitly manufactured fentanyl or fentanyl analogs, and some of it contains no heroin whatsoever. Fentanyl is substantially more potent by weight, is distributed unevenly through a batch, and can produce respiratory depression before a person recognizes anything is wrong. Xylazine, a veterinary sedative that does not respond to naloxone and causes severe soft-tissue wounds, has also appeared in parts of the supply.
For couples this changes two things. First, a tolerance built on one supply offers no protection against the next one. Second, the common safety assumption couples make — that using together means someone is there to help — is only true if that person is conscious, has naloxone, and calls 911. Partners frequently overdose in sequence rather than in tandem. Couples navigating fentanyl exposure alongside heroin should also review our forthcoming guidance on fentanyl addiction treatment for couples and couples detox for fentanyl, both of which address the specific stabilization challenges fentanyl presents.
Few couples who present for heroin treatment are using heroin alone. Methamphetamine is frequently used to counteract sedation, cocaine to extend function, alcohol and benzodiazepines to manage the sharp edges of withdrawal or sleep, and prescription opioids to bridge gaps in supply. Each combination changes the medical picture. Opioids combined with benzodiazepines or alcohol compound respiratory depression and raise overdose risk substantially; benzodiazepine and alcohol withdrawal, unlike opioid withdrawal, can be medically dangerous on their own and require their own supervised protocol. An honest intake assessment about everything both partners are using is the single most useful thing you can do to keep detox safe.
We help both partners at once — separate clinical assessments, separate benefit checks, one coordinated placement across our California referral network. The call is confidential and there is no cost to speak with us.
CouplesRehab.net is an independent admissions and referral resource, not a treatment provider. All clinical decisions are made by licensed providers.
Understanding how a shared opioid problem develops is not about assigning blame. It is about identifying the specific mechanisms treatment has to interrupt, because the couples who relapse together are almost always the ones who addressed the drug and left the mechanism intact.
Two people in the same home share cues, schedules, and stressors. The apartment, the car, the specific hour of the evening, the sound of the other person’s routine — all of it becomes conditioned to use. When both partners use, each functions as a walking trigger for the other in a way no other relationship in either person’s life can replicate. Getting one partner stable while the other continues using is possible, but it is materially harder, and clinicians plan for that difficulty rather than pretending it away.
Opioid dependence creates a logistical partnership. Couples divide the work of obtaining, funding, and timing use, and that cooperation is reinforced daily by the most powerful motivator in opioid addiction: avoiding withdrawal. Watching a partner go into withdrawal is genuinely distressing, and relieving it feels like an act of love. Many couples describe this as the hardest pattern to name in therapy, because it does not feel like enabling from the inside. It feels like care.
Relationships formed or sustained under chronic stress often develop intense attachment cycles built on crisis and relief rather than steady security. One partner may take on rescuing, covering, and managing — losing their own life inside that role — while the other absorbs blame and shame. Both patterns are stable, both feel protective, and both keep use in place. Behavioral couples therapy targets these dynamics directly rather than treating them as background noise, which is a large part of why relationship-inclusive treatment outperforms individual treatment alone for many partnered clients.
A meaningful share of the couples who contact us have one partner with opioid use disorder and one without. The non-using partner is not a bystander. They typically arrive exhausted, hypervigilant, financially depleted, and carrying a version of trauma that no one has named for them. Treatment for these couples includes clinical support for the partner who is not using — psychoeducation, individual therapy, boundary work, and often referral to their own mental health outpatient care — alongside the treatment plan for the partner who is.
Yes, and it is worth being precise about what that means, because the phrase raises expectations that vary widely from program to program.
What couples-inclusive treatment reliably means: both partners are admitted to the same program or coordinated programs, each receives an individual assessment and individual treatment plan, and structured joint sessions — couples therapy, family therapy, shared relapse-prevention planning — are built into the schedule rather than offered as an afterthought. Both partners have their own therapist, their own medical provider, and their own clinical goals.
What varies by facility: whether partners share a room, how soon after admission joint sessions begin, and whether both partners are on-site at the same level of care. Room sharing is uncommon during medical detox and early residential treatment. Most programs stabilize each partner separately first — often for the first several days to two weeks — then introduce joint work once both are medically stable and clinically ready. This is not a punitive policy. Early opioid withdrawal is physically and emotionally raw, and a partner watching it happen is rarely able to focus on their own stabilization. Our page on couples rehab programs outlines how these structures typically differ, and our comparison of inpatient versus outpatient couples treatment covers the trade-offs of each setting.
There are also situations where clinicians will recommend that partners begin at different programs or different levels of care — for example, when one partner needs medically managed withdrawal and the other is appropriate for outpatient care, when there is active safety risk between partners, or when one partner is significantly further along in recovery. Being placed separately is not a failure of couples treatment. Sequencing is often what makes joint work possible later.
Reputable programs screen every couple for intimate partner violence before joint sessions are scheduled, and they do it by interviewing each partner privately. This is a clinical standard, not a formality. Substance use and relationship violence co-occur at elevated rates, opioid withdrawal is a period of heightened irritability and desperation, and couples therapy conducted in the presence of coercion or fear can make a dangerous situation worse by pressuring disclosure that is then punished afterward.
Screening does not automatically disqualify a couple from treatment together. Depending on what it surfaces, a program may proceed with joint work, may delay it while both partners stabilize individually, may treat both partners at separate facilities, or may recommend specialized intervention. Both partners still receive care. The purpose of screening is to make sure the format of that care does not put anyone at risk.
If you are afraid of your partner, or if disclosing honestly in a joint session would put you in danger, tell the admissions coordinator or your assessing clinician privately. That information is handled confidentially and clinically, and it will shape the plan appropriately. The National Domestic Violence Hotline is available 24 hours a day at 1-800-799-7233.
Opioid withdrawal is rarely life-threatening on its own, but it is severe enough that most people cannot complete it without support, and the relapse that ends an unsupervised attempt is the point at which overdose risk is highest. Medically supervised withdrawal management exists to make the process survivable and completable, and to hand the person off into treatment rather than back into the same apartment.
Individual experience varies considerably based on the specific opioid, duration and amount of use, other substances involved, and overall health. Fentanyl exposure in particular can extend the timeline because fentanyl accumulates in body tissue. The following is a general orientation, not a prediction for any specific person.
Phase | General Timing | Commonly Reported |
|---|---|---|
Early withdrawal | Roughly 8–24 hours after last use | Anxiety, restlessness, muscle and bone aches, sweating, watery eyes, runny nose, yawning, insomnia, cravings |
Peak withdrawal | Roughly days 1–3 | Nausea, vomiting, diarrhea, abdominal cramping, goosebumps, dilated pupils, elevated heart rate and blood pressure, chills alternating with sweating, severe agitation |
Subsiding acute phase | Roughly days 4–7 | Physical symptoms ease; fatigue, poor sleep, low mood, and irritability persist; appetite begins returning |
Protracted phase | Weeks to months | Sleep disturbance, low energy, anhedonia, emotional dysregulation, intermittent strong cravings — the window in which ongoing treatment and medication matter most |
Detox lowers tolerance quickly. If either partner returns to their previous amount after even a few days of abstinence, the risk of fatal overdose is dramatically higher than it was before. This is one of the strongest arguments for entering continuing treatment directly from detox rather than going home first, and one of the strongest arguments for medication-assisted treatment, which protects against exactly this scenario. It is also why every couple leaving detox should have naloxone and know how to use it, regardless of how confident either partner feels.
Detox on its own is stabilization, not treatment. It addresses the physical dependence and none of the reasons use started or continued. Couples exploring what supervised withdrawal looks like locally can review couples detox in Los Angeles, and couples who need placement quickly can review same-day couples rehab admissions.
Medication-assisted treatment — increasingly called medication for opioid use disorder — combines FDA-approved medication with counseling and behavioral therapy. For opioid use disorder specifically, it is the most strongly evidence-supported approach available. The Substance Abuse and Mental Health Services Administration identifies these medications as a core component of effective opioid treatment, and the research consistently associates them with improved treatment retention and reduced overdose mortality.
Buprenorphine, dispensed alone (Subutex and generics) or combined with naloxone (Suboxone and generics), is a partial opioid agonist. It occupies opioid receptors strongly enough to suppress withdrawal and craving without producing the effect of full agonists, and its partial action creates a ceiling that limits respiratory depression. It can be prescribed in office-based settings, which makes it the most accessible option for many California couples. Timing of the first dose matters, because starting too early after a full agonist can precipitate withdrawal — the reason induction is done under clinical supervision.
Methadone is a full opioid agonist dispensed through federally certified opioid treatment programs, with daily visits initially and take-home privileges earned over time. Its structure is demanding, but for people with long histories, very high tolerance, heavy fentanyl exposure, or prior failed buprenorphine attempts, it is often the medication that works when others have not.
Naltrexone, most commonly the extended-release injection (Vivitrol), is an opioid antagonist. It blocks opioid receptors rather than activating them, so it produces no opioid effect and no dependence. It requires full detoxification before the first dose — typically seven to ten days opioid-free — which makes it a poor fit for someone still in withdrawal and a strong fit for someone who has already completed detox and wants a non-agonist option.
This is one of the most common sources of friction we hear about, and it is worth preparing for. Prescribing is individualized. One partner may be started on buprenorphine and the other referred to methadone, or one may be on medication while the other is not. That difference reflects tolerance, use history, medical conditions, other medications, prior treatment response, pregnancy, and logistics — not favoritism, not a judgment about who is sicker, and not a comment on who is trying harder. Programs that treat couples well address this in joint sessions early, precisely because the comparison becomes a resentment if it goes unspoken.
Two misconceptions cause real harm. The first is that medication is simply trading one addiction for another. At prescribed doses under medical supervision, these medications stabilize the receptor system rather than producing intoxication, and they allow people to work, parent, and participate in therapy — which is the opposite of what addiction does. The second is that being on medication means you are not really in recovery, a belief that circulates in some peer communities and has pushed people off effective treatment and into fatal overdose. Duration is a clinical decision made with a prescriber. Some people taper after a period of stability; many others benefit from long-term maintenance, and there is no clinical requirement to stop on a schedule.
Medication is also not a standalone solution. It manages the neurobiology so that the therapeutic work — trauma, relationship patterns, co-occurring conditions, rebuilding a life — becomes possible. Couples who use both together do meaningfully better than couples who rely on either alone.
California programs organize care using ASAM criteria, which match intensity to clinical need rather than to preference or budget. Couples do not always enter at the same level, and movement between levels in both directions is normal rather than a sign of failure.
Level of Care | Typical Structure | What It Looks Like for Couples |
|---|---|---|
Medically managed withdrawal (detox) | 24-hour medical and nursing care, typically 3–10 days | Partners usually stabilize separately; MAT initiated; joint contact introduced as each partner becomes medically stable |
Residential / inpatient | 24-hour structured living, commonly 30–90 days | Individual therapy, groups, and scheduled couples sessions; room sharing varies by facility and is rarely immediate |
Partial hospitalization (PHP) | Roughly 5–6 hours daily, 5 days weekly | High clinical intensity with evenings outside the program; often paired with couples-friendly sober living |
Intensive outpatient (IOP) | Roughly 3 hours daily, 3–5 days weekly | Allows return to work or parenting; couples sessions weekly; the most common long-term step for partnered clients |
Outpatient | 1–2 sessions weekly | Ongoing individual and couples therapy, medication management, and relapse-prevention maintenance |
Telehealth and virtual care | Scheduled remote sessions | Extends access across California and keeps couples connected to care when travel, work, or childcare limits attendance |
Recovery housing / sober living | Structured drug-free residence | Some California residences accept couples; others do not — availability is confirmed at placement |
Continuing care and alumni support | Ongoing | Aftercare planning, alumni groups, and peer support for both partners |
Placement is determined at assessment. Couples can review setting-specific detail on inpatient couples rehab, outpatient couples rehab, and couples outpatient treatment, and remote options are covered on our virtual couples therapy page. Couples PHP programming in Los Angeles is covered on a dedicated page currently in development.
Programs differ, but the arc is consistent. Understanding it removes a surprising amount of anxiety from the first week.
Each partner completes a separate biopsychosocial assessment covering substance use history, medical status, psychiatric history, trauma, family circumstances, and recovery goals, plus a private safety screening. Medical evaluation typically includes physical examination, laboratory work, screening for infectious disease associated with injection use, and pregnancy testing where relevant. Two individual treatment plans are produced, along with a shared relationship-focused plan.
Withdrawal is managed, medication is initiated where appropriate, sleep and nutrition begin to normalize, and co-occurring psychiatric symptoms are assessed once the acute phase passes. Clinicians generally wait until this point to make diagnostic judgments about depression or anxiety, because withdrawal mimics both convincingly.
A typical week combines individual therapy, process and psychoeducation groups, scheduled couples sessions, medication management appointments, and skills-based programming. Content addresses opioid-specific material — craving management, overdose prevention, medication adherence — alongside relationship material such as communication, boundaries, financial rebuilding, and trust repair. Where children are involved, family sessions and parenting support are added. Life skills, recreation, and physical wellness are part of the schedule for a practical reason: people leaving heroin use often have to relearn how to fill unstructured time.
Planning begins early, not at the end. It covers the next level of care, continued prescribing and pharmacy logistics, ongoing individual and couples therapy, housing, employment, naloxone access, mutual-aid or peer support participation, and a written joint plan for how the couple will respond if either partner uses again. Couples who leave without that plan tend to improvise it during a crisis, which is the worst possible time.
Couples occasionally ask whether joint sessions can replace individual work. They cannot, and programs that allow that substitution tend to produce fragile outcomes.
Individual therapy is where a person addresses material that belongs to them: trauma history, co-occurring psychiatric conditions, shame, medication response, personal triggers, and goals that are theirs rather than the relationship’s. Some of this cannot be worked on safely in front of a partner, and some of it is not the partner’s to hold. Individual therapy is also where a person rebuilds a self that exists outside the relationship — protective for both recovery and the relationship itself.
Couples therapy addresses the system. Behavioral couples therapy, the most researched relationship-based approach in addiction treatment, uses structured elements such as a daily recovery agreement, communication training, conflict-resolution skills, and deliberate rebuilding of positive shared activity. The evidence base associates it with reduced substance use, improved relationship satisfaction, and better outcomes than individual treatment alone for many partnered clients. Related approaches include emotionally focused work on attachment, family systems therapy, and structured trust-rebuilding protocols. Longer-form coverage lives on our couples rehab programs in Los Angeles page.
Co-occurring psychiatric conditions are the norm among people with opioid use disorder, not a complication. Major depression, generalized anxiety, panic disorder, PTSD and complex trauma, bipolar disorder, ADHD, borderline personality disorder, chronic pain, grief, and suicidal ideation all appear frequently. Treating the opioid use while leaving the psychiatric condition unaddressed produces a predictable pattern: the person stabilizes, the untreated symptoms return with full force, and use resumes as the only reliable relief they have ever found.
Integrated dual diagnosis treatment addresses both simultaneously within one team — coordinated psychiatric care, medication management, trauma-focused therapy, and substance use treatment sharing a single plan. For couples, the picture is often asymmetric: one partner may carry a significant psychiatric diagnosis while the other does not, which changes pacing, energy, and what each partner can reasonably offer the other. Naming that openly in couples sessions prevents a great deal of misinterpretation. Our dual diagnosis treatment for couples page covers the integrated model in depth.
Chronic pain deserves specific mention, since many opioid trajectories begin with a legitimate prescription. Effective programs coordinate non-opioid pain management rather than dismissing the pain, because pain that is ignored reliably returns as a reason to use.
Naloxone is an opioid antagonist that reverses overdose by displacing opioids from receptors and restoring breathing. It is available in California without a personal prescription under the statewide standing order, is carried by most pharmacies, and is distributed free through many county and community programs. Every couple affected by opioid use should have it in the home, in the car, and with anyone who spends time with them — and both partners should know where it is.
Practical guidance every couple should hold: fentanyl contamination means potency is unpredictable regardless of source; a single naloxone dose may not be enough with fentanyl and repeat dosing is often required; naloxone does not reverse xylazine, alcohol, or benzodiazepines, so rescue breathing and emergency medical response still matter; and California’s 911 Good Samaritan protections exist so that people can call for help. Call 911 first, then administer naloxone, then stay with the person. The Centers for Disease Control and Prevention publishes current overdose prevention and response guidance.
Overdose risk is highest immediately after any period of reduced tolerance — following detox, a hospital stay, incarceration, or a stretch of abstinence. This is the specific moment when couples are most likely to tell each other they will be careful, and the specific moment when careful is not sufficient.
Relapse in opioid use disorder is common and clinically anticipated. It is not evidence that treatment failed; it is information about what the plan did not yet cover. For couples, the difference between a lapse that gets addressed and one that ends the recovery of both people is almost entirely a function of what was agreed in advance.
A workable couples relapse plan is written, specific, and agreed while both partners are stable. It identifies individual and shared triggers, names who each partner contacts first and what that person is authorized to do, specifies how a lapse is disclosed and what the response will be, and states plainly that the response is a return to treatment rather than the end of the relationship. It includes naloxone location and training, medication adherence checkpoints, and a defined threshold for stepping back up to a higher level of care.
One structural principle matters more than the rest: each partner needs recovery supports that do not depend on the other. Separate therapists, separate peer groups, separate friendships. When both partners’ entire recovery infrastructure is shared, one person’s destabilization takes both down. Ongoing support is covered on our couples rehab programs page, and the experiences on our success stories page illustrate how couples have navigated setbacks without losing the relationship.
Where children are involved, treatment planning has to account for them from the first phone call. Practical questions — who cares for the children if both partners enter residential care, how visitation works, what to tell a seven-year-old versus a fifteen-year-old — are ordinary admissions conversations, and coordinators handle them regularly. Children in households affected by opioid use frequently carry anxiety, hypervigilance, academic disruption, and a persistent sense of responsibility for adult problems. Age-appropriate family therapy gives them accurate information and permission to stop managing what was never theirs.
Trust rebuilding is slower than most couples expect and does not respond to promises. It is built through repeated small demonstrations of reliability over months: consistent attendance, transparency about money and time, follow-through on ordinary commitments, and honesty about craving before it becomes a crisis. Extended family relationships often need the same patient repair. Guidance for couples with children is covered on a dedicated page currently in development.
Programs in our California network work with married couples, engaged couples, long-term unmarried partners, and couples at every stage of stability. Specific considerations come up often enough to name.
Most California couples pay for treatment primarily through commercial insurance. Under federal parity law and the Affordable Care Act, substance use disorder treatment is an essential health benefit, and most PPO plans provide coverage across detox, residential, PHP, IOP, and outpatient care — including medication for opioid use disorder.
Coverage is verified per person, even for partners on the same policy. Each partner has their own deductible status, authorization requirements, and medical-necessity determination. Verification confirms active coverage and effective dates, in-network and out-of-network benefits, deductible and out-of-pocket maximum status, whether prior authorization is required for each level of care, and which behavioral health organization actually administers the benefit — plans frequently carve substance use benefits out to a managed behavioral health organization, and that entity is who makes the determination. Verification is a benefits check, not a guarantee of payment or a coverage decision.
Higher levels of care typically require prior authorization before admission and concurrent review during the stay, in which the program periodically justifies continued medical necessity. Authorizations are commonly granted in short increments and extended as clinically indicated. Because determinations are individual, partners occasionally receive different lengths of authorization, which is a common and usually resolvable source of stress. When a request is denied, plans are required to provide appeal rights, and programs routinely pursue peer-to-peer review.
Plan-level detail is available for Aetna, Anthem, Cigna, Kaiser Permanente, Humana, UnitedHealthcare, and additional carriers. Blue Shield, Health Net, Magellan, and Optum pages are in development. General coverage guidance is on our insurance overview, and a no-cost benefits check for both partners can be started through our free assessment.
Out-of-network benefits, single-case agreements, private pay arrangements, and payment plans are all worth asking about when in-network options are limited. Couples without commercial coverage should also ask about California’s public treatment system and county behavioral health access points; our local drug treatment programs page is a starting point.
Benefits are verified separately for each partner — deductibles, authorization requirements, and in-network status are individual. We can run both checks in a single call.
A benefits check confirms plan details only. It is not a guarantee of coverage or payment, which is determined by your insurer.
Our referral network extends across the state, which matters more in opioid treatment than in most other areas of behavioral health. Leaving the immediate environment where use occurred — the neighborhood, the contacts, the routine — removes a substantial portion of the cue exposure driving craving during the earliest and most fragile weeks.
Placement options span Los Angeles County and the greater Los Angeles metro area, Orange County, San Diego, the Inland Empire including Riverside and San Bernardino, Ventura and Santa Barbara counties, the Central Coast, Sacramento, the Bay Area, and Northern California. Statewide coverage is outlined on our couples rehab California page, and geographic detail is available through locations. Couples relocating from outside California for treatment are common, and coordinators handle travel logistics as part of admissions.
The first call is a conversation, not a commitment. A coordinator asks about substance use for both partners, current medical and psychiatric status, safety concerns, insurance, and practical constraints such as children, work, and pets. The call is confidential.
From there, both partners complete clinical assessments determining appropriate level of care and MAT candidacy. Benefits are verified separately for each partner, authorization is requested where required, and program options are presented with the trade-offs stated plainly — including whether both partners can be placed at the same facility. Admission is coordinated with transportation arranged where needed, and couples entering care together are usually admitted the same day.
Bring photo identification, insurance cards, a list of current medications in original containers, physician and pharmacy contact information, comfortable clothing, and any court or custody documentation if relevant. Programs will provide their own specific list. If either partner is in active withdrawal or unstable, say so on the first call so intake can be expedited appropriately. Reach us through the contact page or by phone at (310) 622-9280.
Speak confidentially with a coordinator about detox, medication-assisted treatment, residential care, and couples-inclusive programs across California. No cost, no obligation.
Both partners can enter the same detox facility at the same time, and that is the usual arrangement. Most programs stabilize partners in separate rooms or separate units during the acute phase, because early opioid withdrawal is severe and each person needs undivided clinical attention. Contact and joint sessions are typically introduced once both partners are medically stable.
It depends entirely on the facility and the phase of treatment. Room sharing is uncommon during detox and early residential care and becomes more available at PHP, IOP, and in some couples-friendly sober living residences. Ask about it directly at admissions — the answer varies by program and can be confirmed before you commit.
Yes, and it happens frequently. Medication decisions are individualized based on tolerance, use history, medical conditions, other prescriptions, pregnancy, and prior treatment response. One partner may be started on buprenorphine while the other is referred to methadone or is not started on medication at all. It is a clinical determination, not a judgment about either person.
Detox commonly runs 5–10 days. Residential treatment typically runs 30–90 days. PHP and IOP frequently continue for several weeks to several months afterward, with outpatient therapy and medication management continuing well beyond that. Length is determined by clinical progress and authorization, and partners are not always on identical timelines.
Most commercial PPO plans provide coverage for substance use treatment across the continuum of care, including medication for opioid use disorder. Coverage is verified separately for each partner, and higher levels of care generally require prior authorization. A benefits check confirms what your specific plan provides — it is not a guarantee of payment, which is determined by your plan.
That is a common situation and treatment accommodates it. The partner with opioid use disorder enters the clinically appropriate level of care, while the other partner participates in couples therapy, family sessions, and psychoeducation, and is often referred for their own individual support. Living alongside active addiction takes a real toll that deserves treatment in its own right.
Relapse is anticipated in opioid use disorder and is treated as clinical information rather than as grounds for discharge. The typical response is reassessment, possible return to a higher level of care, review of medication, and joint sessions addressing what the plan missed. Overdose risk is highest after any period of reduced tolerance, which is why naloxone access and immediate re-engagement with treatment matter so much.
Yes, and it is strongly recommended. Untreated opioid use disorder in pregnancy carries serious risk, and unmanaged withdrawal carries additional fetal risk, which is why medication-assisted treatment with buprenorphine or methadone is the standard of care rather than detoxification. California has specialized perinatal programs, and coordinators can prioritize placement accordingly.
The treatment framework is the same, but fentanyl changes the details. Fentanyl accumulates in body tissue, which can lengthen withdrawal and complicate the timing of buprenorphine induction, and it raises overdose risk substantially. Because most street heroin in California now contains fentanyl, programs generally plan for fentanyl exposure regardless of what a person believes they were using.
Yes, with planning. Childcare arrangements are part of the admissions conversation, and options include staggered admission so one partner remains home, family placement, outpatient levels of care that allow both partners to remain in the household, or programs that accommodate family visitation and involvement.
Often yes. Same-day and next-day placement is frequently available depending on bed availability, insurance verification, and clinical acuity. Active withdrawal, medical instability, or recent overdose generally moves a case to the front of the queue. Timing is confirmed during the assessment call rather than promised in advance.
No. Programs work with married couples, engaged couples, domestic partners, and long-term unmarried partners. What matters clinically is that the relationship is a significant and ongoing part of both people's lives, not its legal status.
It happens, usually because partners need different levels of care, because one program cannot accommodate both, or because a safety screening indicated separate placement is safer. Coordinated care between programs allows joint sessions to continue, often by telehealth, and partners frequently reunite in the same program at a later level of care.
Yes. Substance use treatment records receive protection under HIPAA and the additional federal confidentiality rules at 42 CFR Part 2. Note that information is not automatically shared between partners either — each of you would need to sign a release for the other to receive details about your care.
That is a decision for you and your clinicians, not one anyone should make for you from the outside. Many couples find that recovering together strengthens both the relationship and each person's outcome. Some find that structured separation during early treatment is safer or more effective. Programs work toward the healthiest outcome for both individuals and support whatever the couple decides, including a decision to separate.
Ask whether the facility is licensed and certified by the California Department of Health Care Services, whether it holds Joint Commission or CARF accreditation, whether medication for opioid use disorder is offered or arranged, whether licensed clinicians deliver the couples therapy, and what the aftercare plan includes. Be cautious with anyone guaranteeing outcomes or pressuring an immediate decision — legitimate providers do neither.
Heroin addiction convinces couples that the situation is beyond repair — that too much has been lost, too many promises broken, too much money gone, too many attempts already failed. None of that is a reliable prediction of what happens next. Opioid use disorder is a treatable medical condition, effective medications exist, and relationship-centered treatment has a real evidence base behind it. Couples who have been using for years, who have relapsed repeatedly, and who arrive certain that they are the exception build stable recovery every day in California.
CouplesRehab.net can help you understand the options, verify benefits for both partners, and connect with licensed California programs equipped to treat you as two individuals and as a couple. The conversation is confidential, there is no cost to speak with a coordinator, and you are not committing to anything by asking questions.